Academic literature on the topic 'Roflumilast'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Roflumilast.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Roflumilast"
Yosipovitch, Gil, Shawn Kwatra, James Del Rosso, et al. "Reduction in Pruritus Across Indications in Phase 3 Trials of Topical Roflumilast." SKIN The Journal of Cutaneous Medicine 9, no. 4 (2025): s587. https://doi.org/10.25251/579nct27.
Full textLivingston, Nicholas R., Peter CT Hawkins, James Gilleen, et al. "Preliminary evidence for the phosphodiesterase type-4 inhibitor, roflumilast, in ameliorating cognitive flexibility deficits in patients with schizophrenia." Journal of Psychopharmacology 35, no. 9 (2021): 1099–110. http://dx.doi.org/10.1177/02698811211000778.
Full textAlispahic, Imane Achir, Rikke Sørensen, Josefin Eklöf, et al. "Roflumilast in Severely Ill Patients with Chronic Obstructive Pulmonary Disease with Frequent Exacerbations: Risk of Pneumonia Hospitalization and Severe Exacerbations." Journal of Clinical Medicine 9, no. 5 (2020): 1442. http://dx.doi.org/10.3390/jcm9051442.
Full textNicolas, Samar E., Michael D. Bear, Abir O. Kanaan, Oana Andreia Coman, and Lorena Dima. "Roflumilast 0.3% Cream: a Phosphodiesterase 4 Inhibitor for the Treatment of Chronic Plaque Psoriasis." American Journal of Therapeutics 30, no. 6 (2023): e535-e542. http://dx.doi.org/10.1097/mjt.0000000000001678.
Full text&NA;. "Roflumilast." Drugs in R & D 5, no. 3 (2004): 176–81. http://dx.doi.org/10.2165/00126839-200405030-00009.
Full textSanford, Mark. "Roflumilast." Drugs 70, no. 12 (2010): 1615–27. http://dx.doi.org/10.2165/11205930-000000000-00000.
Full textChristie, P. "Roflumilast." Drugs of Today 41, no. 10 (2005): 667. http://dx.doi.org/10.1358/dot.2005.41.10.920428.
Full textCada, Dennis J., Terri L. Levien, and Danial E. Baker. "Roflumilast." Hospital Pharmacy 46, no. 8 (2011): 597–606. http://dx.doi.org/10.1310/hpj4608-597.
Full textFabbri, Leonardo M., Bianca Beghé, Uma Yasothan, and Peter Kirkpatrick. "Roflumilast." Nature Reviews Drug Discovery 9, no. 10 (2010): 761–62. http://dx.doi.org/10.1038/nrd3276.
Full textSorbera, L. A., P. A. Leeson, and J. Castañer. "Roflumilast." Drugs of the Future 25, no. 12 (2000): 1261. http://dx.doi.org/10.1358/dof.2000.025.12.604045.
Full textDissertations / Theses on the topic "Roflumilast"
Walsh, Nicola Margaret. "Comparison of the modes of action of Apremilast and Roflumilast." Thesis, University of Glasgow, 2015. http://theses.gla.ac.uk/7427/.
Full textRieder, Florian. "Wirkung der spezifischen Phosphodiesterase-Inhibitoren Roflumilast und Pumafentrine im Mausmodell der Dextran-Sodium-Sulfat-induzierten Kolitis." Diss., lmu, 2004. http://nbn-resolving.de/urn:nbn:de:bvb:19-28038.
Full textПриступа, Людмила Никодимівна, Людмила Никодимовна Приступа, Liudmyla Nykodymivna Prystupa та Ф. О. Красненко. "Ефективність рофлуміласту у хворих на хронічне обструктивне захворювання легень із ожирінням". Thesis, Сумський державний університет, 2017. http://essuir.sumdu.edu.ua/handle/123456789/55445.
Full textVictoni, Tatiana. "Etude de l'activation de cellules pulmonaires par un extrait de fumée de cigarette ou par l'élastase du neutrophile associés au lipopolysaccharideEtude des effets d'un inhibiteur de phophodiestérase de type 4, le roflumilast." Phd thesis, Université Rennes 1, 2013. http://tel.archives-ouvertes.fr/tel-00950306.
Full textFernandes, Diogo Miguel Pereira. "Inibidores seletivos e não seletivos da fosfodiesterase no tratamento da DPOC." Master's thesis, 2018. http://hdl.handle.net/10316/82803.
Full textRieder, Florian [Verfasser]. "Wirkung der spezifischen Phosphodiesterase-Inhibitoren Roflumilast und Pumafentrine im Mausmodell der Dextran-Sodium-Sulfat-induzierten Kolitis / vorgelegt von Florian Rieder." 2004. http://d-nb.info/972835911/34.
Full textBooks on the topic "Roflumilast"
Verfasser, Schließmann Stephan J., Kirschbaum Andreas Verfasser, Plönes Till 1976 Verfasser, et al., eds. Roflumilast-N-oxide induces surfactant protein expression in human alveolar epithelial cells type II. Universität, 2012.
Find full textBlokdijk, G. J. Roflumilast; Complete Self-Assessment Guide. CreateSpace Independent Publishing Platform, 2018.
Find full textBook chapters on the topic "Roflumilast"
Graham, Garry G., and Kevin D. Pile. "Phosphodiesterase 4 Inhibitors: Apremilast and Roflumilast." In Compendium of Inflammatory Diseases. Springer Basel, 2016. http://dx.doi.org/10.1007/978-3-7643-8550-7_56.
Full textGraham, Garry G., and Kevin D. Pile. "Phosphodiesterase 4 Inhibitors: Apremilast and Roflumilast." In Encyclopedia of Inflammatory Diseases. Springer Basel, 2015. http://dx.doi.org/10.1007/978-3-0348-0620-6_56-1.
Full textMedvedova, I., M. Prso, A. Eichlerova, D. Mokra, P. Mikolka, and J. Mokry. "Influence of Roflumilast on Airway Reactivity and Apoptosis in Ovalbumin-Sensitized Guinea Pigs." In Advances in Experimental Medicine and Biology. Springer International Publishing, 2014. http://dx.doi.org/10.1007/5584_2014_77.
Full text"Roflumilast." In Drugs Handbook 2012–2013. Bloomsbury Academic, 2011. http://dx.doi.org/10.5040/9781350363595.art-1525.
Full text"Roflumilast." In Checkliste Arzneimittel A–Z, edited by Detlev Schneider and Frank Richling. Georg Thieme Verlag, 2013. http://dx.doi.org/10.1055/b-0034-82738.
Full text"Roflumilast to Simeticon." In Checkliste Arzneimittel A - Z, edited by Schneider and Richling. Georg Thieme Verlag, 2017. http://dx.doi.org/10.1055/b-0037-144509.
Full textRuiz Briones, Paula, María Sagrario Pernia López, Félix Jesús García Moreno, et al. "Validación galénica y experiencia clínica de una pomada de Roflumilast 0,166mcg/g en orobase para tratamiento de aftas orales persistentes." In Libro de comunicaciones 69 Congreso SEFH. Sociedad Española de Farmacia Hospitalaria, 2024. http://dx.doi.org/10.62917/24.69.0712.
Full textConference papers on the topic "Roflumilast"
Kammerer, Susanne. "Topical roflumilast beneficial in atopic dermatitis." In American Academy of Dermatology 2023, edited by Peter van de Kerkhof. Medicom Medical Publishers, 2023. http://dx.doi.org/10.55788/194ffc74.
Full textRhee, Chin Kook, Jee Hye Kim, Shin Young Kim, Chan Kwon Park, and Hyoung Kyu Yoon. "Effect of roflumilast on neutrophilic asthma model." In ERS International Congress 2017 abstracts. European Respiratory Society, 2017. http://dx.doi.org/10.1183/1393003.congress-2017.pa1147.
Full textSavelikhina, Iryna, Mykola Ostrovskyy, Kseniia Ostrovska, Mariana Kulynych-Miskiv, Oleksandr Varunkiv, and Kostiantyn Shvets. "Biomarkers in COPD: Beneficial effects of roflumilast." In ERS International Congress 2017 abstracts. European Respiratory Society, 2017. http://dx.doi.org/10.1183/1393003.congress-2017.pa1071.
Full textRhee, Chin Kook, Yong Bum Park, and Hyoung Kyu Yoon. "Risk factors for discontinuation of roflumilast in COPD patients." In ERS International Congress 2017 abstracts. European Respiratory Society, 2017. http://dx.doi.org/10.1183/1393003.congress-2017.pa1060.
Full textStanford, D., L. W. Rasmussen, J. LaFontaine, A. Allen, E. L. Burnham, and S. V. Raju. "Roflumilast Reverses Alcohol Impairment of CFTR Function and Mucus Clearance." In American Thoracic Society 2020 International Conference, May 15-20, 2020 - Philadelphia, PA. American Thoracic Society, 2020. http://dx.doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a1896.
Full textDomvri, Kalliopi, Konstantinos Porpodis, Antonis Papaioannou, et al. "Neutrophils and spirometry changes in COPD patients treated with roflumilast." In Annual Congress 2015. European Respiratory Society, 2015. http://dx.doi.org/10.1183/13993003.congress-2015.pa3979.
Full textKammerer, Susanne. "Roflumilast foam led to high response rates in seborrheic dermatitis." In EADV Congress 2022, edited by Peter van de Kerkhof. Medicom Medical Publishers, 2022. http://dx.doi.org/10.55788/b3195d65.
Full textFeineis, Martin, Charlott Terschluse, Louis Jouanjan, Björn Frye, and Dajana Stolz. "Roflumilast in sarcoidosis: A retrospective analysis of 51 sarcoidosis patients." In ERS Congress 2024 abstracts. European Respiratory Society, 2024. http://dx.doi.org/10.1183/13993003.congress-2024.pa2476.
Full textWatz, Henrik, Nitin Bagul, Ken Nip, et al. "Tolerability of different dosing regimens of roflumilast in severe COPD (OPTIMIZE)." In ERS International Congress 2016 abstracts. European Respiratory Society, 2016. http://dx.doi.org/10.1183/13993003.congress-2016.pa308.
Full textHanania, Nicola A., Mark T. Dransfield, Udo-Michael Goehring, Hassan Lakkis, and Paul Rowe. "Efficacy Of Roflumilast In Elderly Patients With Chronic Obstructive Pulmonary Disease." In American Thoracic Society 2011 International Conference, May 13-18, 2011 • Denver Colorado. American Thoracic Society, 2011. http://dx.doi.org/10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a3087.
Full text